Acute DiverticulitisNCT01840852
Sleep and Cytokines During Acute Diverticulitis
An observational study of Acute Diverticulitis, run by Herlev Hospital at 1 site in Denmark.
Trial summary
The purpose of this study is to investigate sleep disturbances during Acute uncomplicated diverticulitis by polysomnography. The investigators hypothesis is the inflammation causes REM(rapid eye movement)-sleep reduction and this is correlated with plasma cytokine levels. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Acute Diverticulitis
- How many people
- 13 participants
- Where
- 1 siteDenmark
- Study dates
- Apr 2013to Nov 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 16 x Acute uncomplicated diverticulitis (Hansen and stock stage 1) patients aged 18-75 years managed by antibiotic treatment at Herlev Hospital.
Who may be able to join
- CT-verified diverticulitis patients managed by antibiotic treatment at Herlev Hospital
- Pain and fever occurred less than 72 hours prior to the admission
- ASA (American Society of Anesthesiologists) score I to III
Who cannot join
- Surgical intervention needed
- Complicated diverticulitis
- Complications in relation to diverticulitis
- Pain and fever occurred more than 72 hours prior to the admission
- In anticoagulant treatment and heart rate control treatment
- Known Autoimmune disease
Show all 18Show fewer
- Known medically treated sleep-disorder (insomnia, restless legs etc.) and sleep apnea
- Shift-work or jetlag
- Daily use of opioid, psychopharmaca, opioids or anxiolytics (including Hypnotics)
- Known psychiatry conditions in treatment with psychopharmaca
- Daily alcohol intake of more than 5 units or drug abuse
- Missing written consent
- Diabetes Mellitus
- Predicted bad compliance
- Pregnant or breast-feeding
- Urine or fecal incontinence
- Severe kidney disease
- Current cancer
Trial locations and contacts
1 site in 1 country.
About this study
Official title: the Effects of Inflammatory Cytokines on Sleep During Acute Diverticulitis
The purpose of this study is to investigate sleep disturbances during Acute uncomplicated diverticulitis by polysomnography. The investigators hypothesis is the inflammation causes REM(rapid eye movement)-sleep reduction and this is correlated with plasma cytokine levels.
Read the detailed description
An increasing number of experimental studies have showed that inflammation can induce disturbances in sleep architecture, mediated by cytokines. Sleep is important both in health and disease processes and can affect recovery, morbidity and mortality.
Studies have been done on sleep disturbances after major and minor GI-surgery but never in relation to none surgical inflammatory diseases, namely acute diverticulitis.
This study will investigate sleep architecture by Polysomnography and inflammation by levels of pro inflammatory cytokines in plasma.
Following methods will be applied
Device: Polysomnograph - Embla Titanium (Natus Medical Incorporated, USA)
Procedure: Plasma cytokines (IL-2, IL-6 and TNF(tumor necrosis factor-alfa)
Procedure: Plasma CRP(C reactive protein) and leukocytes
- Conditions
- Acute Diverticulitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| acute uncomplicated diverticulitis | CT-verified acute uncomplicated diverticulitis managed by antibiotics |
What is being measured
The primary outcome is the main question the study is designed to answer.
change in Sleep architecture during acute uncomplicated diverticulitis from baseline at the remission (30th day)
Sleep architecture measured by Polysomnography (awake, stadium I-IV, REM sleep, sleep latency, awakenings)
Measured: 1st, 2nd and 30th nights following the admission
change in cytokine levels in plasma during the acute uncomplicated diverticulitis from baseline levels at remission
the Blood sample is taken prior to night sleep; Cytokines are measured by commercial ELISA-kits
Measured: 1st, 2nd and 30th nights following the admission
change in CRP level in plasma during the acute uncomplicated diverticulitis from baseline levels at remission
the Blood sample is taken prior to night sleep; CRP is measured by standardized conventional method
Measured: 1st, 2nd and 30th nights following the admission
change in leucocyte level in plasma during the acute uncomplicated diverticulitis from baseline levels at remission
the Blood sample is taken prior to night sleep; Leucocyte is measured by standardized conventional method
Measured: 1st, 2nd and 30th nights following the admission
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Apr 2013 (estimated)
- Study startApr 2013
- Primary completionNov 2013
- Study completionNov 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute DiverticulitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Prospective
- Enrolment
- 13 participants (actual)
Sponsor and investigators
- Lead sponsor
- Herlev Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Lundbeck Foundation
- Responsible party
- Principal investigator, Ismail Gögenür, Herlev Hospital
- Investigators
- Ismail Gögenur, M.D., Principal investigator, University of Copenhagen, Herlev Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01840852
- Sponsor's protocol ID
- CHU-1
- Status last verified
- Feb 2014
- First submitted
- 13 Apr 2013
- Last updated
- 25 Feb 2014
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- the Effects of Inflammatory Cytokines on Sleep During Acute Diverticulitis
- ClinicalTrials.gov ID
- NCT01840852
- Acronym / sponsor ID
- CHU-1
- Conditions
- Acute Diverticulitis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 13 participants (actual)
- Lead sponsor
- Herlev HospitalUniversity, hospital or other
- Collaborators
- Lundbeck Foundation
- Study start
- Apr 2013
- Primary completion
- Nov 2013 (actual)
- Study completion
- Nov 2013 (actual)
- First posted
- 26 Apr 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to investigate sleep disturbances during Acute uncomplicated diverticulitis by polysomnography. The investigators hypothesis is the inflammation causes REM(rapid eye movement)-sleep reduction and this is correlated with plasma cytokine levels.
Detailed description
An increasing number of experimental studies have showed that inflammation can induce disturbances in sleep architecture, mediated by cytokines. Sleep is important both in health and disease processes and can affect recovery, morbidity and mortality.
Studies have been done on sleep disturbances after major and minor GI-surgery but never in relation to none surgical inflammatory diseases, namely acute diverticulitis.
This study will investigate sleep architecture by Polysomnography and inflammation by levels of pro inflammatory cytokines in plasma.
Following methods will be applied
Device: Polysomnograph - Embla Titanium (Natus Medical Incorporated, USA)
Procedure: Plasma cytokines (IL-2, IL-6 and TNF(tumor necrosis factor-alfa)
Procedure: Plasma CRP(C reactive protein) and leukocytes
Study design
- Observational model
- Case crossover
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| acute uncomplicated diverticulitis | – | –CT-verified acute uncomplicated diverticulitis managed by antibiotics |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 16 x Acute uncomplicated diverticulitis (Hansen and stock stage 1) patients aged 18-75 years managed by antibiotic treatment at Herlev Hospital.
Key inclusion criteria (3 listed)
- CT-verified diverticulitis patients managed by antibiotic treatment at Herlev Hospital
- Pain and fever occurred less than 72 hours prior to the admission
- ASA (American Society of Anesthesiologists) score I to III
Key exclusion criteria (18 listed)
- Surgical intervention needed
- Complicated diverticulitis
- Complications in relation to diverticulitis
- Pain and fever occurred more than 72 hours prior to the admission
- In anticoagulant treatment and heart rate control treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
change in Sleep architecture during acute uncomplicated diverticulitis from baseline at the remission (30th day)
Time frame: 1st, 2nd and 30th nights following the admission
Sleep architecture measured by Polysomnography (awake, stadium I-IV, REM sleep, sleep latency, awakenings)
change in cytokine levels in plasma during the acute uncomplicated diverticulitis from baseline levels at remission
Time frame: 1st, 2nd and 30th nights following the admission
the Blood sample is taken prior to night sleep; Cytokines are measured by commercial ELISA-kits
change in CRP level in plasma during the acute uncomplicated diverticulitis from baseline levels at remission
Time frame: 1st, 2nd and 30th nights following the admission
the Blood sample is taken prior to night sleep; CRP is measured by standardized conventional method
change in leucocyte level in plasma during the acute uncomplicated diverticulitis from baseline levels at remission
Time frame: 1st, 2nd and 30th nights following the admission
the Blood sample is taken prior to night sleep; Leucocyte is measured by standardized conventional method
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2014.
Related trials for Acute Diverticulitis
Not yet recruiting
Improving the Treatment of Acute Uncomplicated Diverticulitis in Routine Care
Diverticulitis
RecruitingPhase 2
APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)
Acute Uncomplicated Diverticulitis
Not yet recruitingObservational study
Analysis of the Role of the Microbiota in Diverticular Disease
Diverticular Disease of Colon, Acute Diverticulitis
Not yet recruitingObservational study
AIDE: Decision Support for Anastomosis or Colostomy in Emergency Surgery for Complicated Acute Diverticulitis
Complicated Diverticulitis, Acute Diverticulitis
RecruitingObservational study
Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL Study
Intra Abdominal Infections, Appendicitis Acute
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ismail Gögenur, M.D. principal investigator
University of Copenhagen, Herlev Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Diverticulitis, run by Herlev Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Feb 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
change in Sleep architecture during acute uncomplicated diverticulitis from baseline at the remission (30th day) (time frame: 1st, 2nd and 30th nights following the admission). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2014.